What is Palvella Therapeutics's enterprise value?

Palvella Therapeutics (PVLA) reported enterprise value of $1.58B in Q1 2026.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Palvella Therapeutics PVLA Enterprise value

Enterprise value at other companies

Relay Therapeutics, Inc.RLAY

$1.61B+304%

Viridian Therapeutics, Inc.VRDN

$1.86B+85.0%

ANI PharmaceuticalsANIP

$1.72B+5.8%

PrecigenPGEN

$1.46B+234%

Arcutis Biotherapeutics, Inc.ARQT

$3B+57.0%

Kodiak Sciences IncKOD

$2.21B+2,798%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Calculated from Palvella Therapeutics’s reported figures.

$1.8Bmarket cap+$584.0Ktotal debt−$206.4Mcash and equivalents=$1.58B

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's enterprise value?: Palvella Therapeutics (PVLA) reported enterprise value of $1.58B in Q1 2026.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.